Quest Diagnostics (DGX) Gross Profit (2009 - 2026)

Quest Diagnostics has disclosed Gross Profit across 18 years of filings, most recently posting $942.0 million for Q1 2026.

• Gross Profit for Q1 2026 came in at $942.0 million, up 9.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.7 billion (up 12.23% YoY), and the FY2025 annual result was $3.7 billion, up 12.98% from the prior year.
• Gross Profit came in at $942.0 million for Q1 2026 at Quest Diagnostics, up from $910.0 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $965.0 million in Q1 2022 to a low of $736.0 million in Q4 2023.
• The 5-year median for Gross Profit is $842.0 million (2022), against an average of $843.4 million.
• Across the five-year window, Gross Profit retreated 26.12% in 2022 and advanced 17.29% in 2025, its largest moves.
• Quest Diagnostics' Gross Profit stood at $758.0 million in 2022, then decreased by 2.9% to $736.0 million in 2023, then grew by 16.58% to $858.0 million in 2024, then gained by 6.06% to $910.0 million in 2025, then climbed by 3.52% to $942.0 million in 2026.
• The last three Gross Profit figures came in at $942.0 million (Q1 2026), $910.0 million (Q4 2025), and $949.0 million (Q3 2025), per Business Quant data.